Epidemiology and Statistics
- Ehrlichiosis is the general name used to describe diseases caused by the bacteria Ehrlichia chaffeensis, E. ewingii, or E. muris eauclairensis in the United States.
- The majority of reported cases are due to infection by E. chaffeensis.
- Ehrlichiosis, previously referred to as human monocytic ehrlichiosis (HME), was first recognized as a human disease in the United States in the late 1980s but did not become a reportable disease until 1999, with the first data reported in 2000.
- CDC compiles the number of cases reported by state and local health departments and reports national trends. Disease caused by E. ewingii was not considered separately reportable until 2008.
In 2008, the ehrlichiosis case definition was split into four categories:
- Ehrlichia chaffeensis infection
- Ehrlichia ewingii infection
- Anaplasma phagocytophilum infection
- Undetermined ehrlichiosis/anaplasmosis
Infections from the recently discovered E. muris eauclairensis are still reported under the undetermined ehrlichiosis/anaplasmosis category. Due to low reporting numbers of other ehrlichioses, national surveillance data shown below only relate to cases of E. chaffeensis ehrlichiosis.
- The number of ehrlichiosis cases due to E. chaffeensis reported to CDC has increased steadily since the first year of disease reporting.
- In the year 2000, only 200 cases of ehrlichiosis were reported, while in 2016 more than 1,377 cases were reported.
- Notably, while cases and incidence rose, the case fatality rate (i.e., the proportion of ehrlichiosis patients that died as a result of infection) has declined since 2000, although the case fatality rate in recent publications is still roughly 1% of cases.
Figure 1 – Number of U.S. ehrlichiosis cases caused by Ehrlichia chaffeensis and reported to CDC, 2000–2016.
The graph displays the number of human cases of ehrlichiosis caused by Ehrlichia chaffeensis reported to CDC annually from 2000 through 2016. *From 2000 to 2008, ehrlichiosis was included in the reporting category “human monocytic ehrlichiosis” in reports to NNDSS. **Since 2008, ehrlichiosis has been reported to NNDSS under the categories “Ehrlichia chaffeensis infections,” “Ehrlichia ewingii infections,” and “Undetermined ehrlichiosis/anaplasmosis infections”, which include infections caused by Ehrlichia muris eauclairensis. Only E. chaffeensis infections are shown above.
- Although cases of ehrlichiosis can occur during any month of the year, the majority of cases reported to CDC have an illness onset during the summer months with a peak in cases typically occurring in June and July.
- This period coincides with the season for increased numbers of adult and nymphal lone star ticks. All stages of this tick feed on humans, however, only adult and nymphal ticks spread E. chaffeensis to humans.
Figure 2 – Number of reported ehrlichiosis cases caused by Ehrlichia chaffeensis by month of onset, 2000–2016
The figure shows the number of ehrlichiosis cases caused by Ehrlichia chaffeensis reported from 2000 through 2016 by month of onset to give the seasonal trends. There are cases reported in each month of the year, however, most are reported in June and July. More than 50% of all cases occur in June and July.
- Ehrlichiosis is most frequently reported from the southeastern and south-central United States, from the Eastern Coast extending westward to Texas.
- These areas overlapping with the known geographic distribution of the lone star tick (Amblyomma americanum), the primary tick vector of E. chaffeensis and E. ewingii.
- In 2016, four states (Missouri, Arkansas, New York, and Virginia) accounted for 50% of all reported cases of ehrlichiosis.
- Ehrlichiosis caused by E. muris eauclairensis has been found in patients living in Minnesota and Wisconsin.
Figure 3 – Annual reported incidence (per million population) for E. chaffeensis in the United States for 2010. (NN= Not notifiable)
This figure shows the incidence of ehrlichiosis cases caused by Ehrlichia chaffeensis by state in 2016 per million persons. Ehrlichiosis was not notifiable in Alaska, Colorado, the District of Columbia, Hawaii, Idaho, or New Mexico in 2016. The incidence rate was zero for Arizona, California, Indiana, Nevada, South Carolina, South Dakota, Utah, Washington, and Wyoming. The incidence rate in Connecticut was 0.3 cases per million persons. Incidence ranged from 0.3 to 1.6 cases per million persons in Oregon, Pennsylvania, Texas, Louisiana, Ohio, Michigan, Montana, Minnesota, Georgia, Iowa, Florida, Massachusetts, and Alabama. Incidence ranged from 1.6 to 6.4 cases per million persons in Illinois, North Dakota, Mississippi, Vermont, West Virginia, Nebraska, Maine, New Hampshire, Wisconsin, Maryland, and North Carolina. The highest incidence rates, greater than 6.4 cases per million persons, were found in New Jersey, New York, Kentucky, Virginia, Tennessee, Delaware, Oklahoma, Kansas, Missouri, Rhode Island, and Arkansas.
- From a review of the national surveillance data, cases of ehrlichiosis are more frequently reported in men than women.
- People between 60 to 69 years of age account for the highest number of cases.
- People with compromised immune systems (e.g., resulting from cancer treatments, advanced HIV infection, prior organ transplants, or some medications) might be at increased risk for severe disease.
E. ewingii Surveillance
- E. ewingii infections are impossible to distinguish from E. chaffeensis infections based on clinical signs alone. As a result, some proportion of cases currently reported as E. chaffeensis infection may actually be due to E. ewingii.
- Currently, there is no available serologic test that can distinguish between diseases cause by these agents, and surveillance for E. ewingii ehrlichiosis is based on detection of the organism using molecular-based diagnostic tests.
- In total, 140 cases of E. ewingii ehrlichiosis were reported to CDC from 2008–2016. No fatal cases of E. ewingii ehrlichiosis have been reported.
- This reporting category reflects cases that showed clinical and laboratory signs consistent with either an ehrlichiosis or anaplasmosis infection, but which could not be listed as a specific organism due to the limitations of diagnostic test results.
- This category is also used to report cases of ehrlichiosis not caused by E. chaffeensis or E. ewingii (such as cases resulting from infection with the newly identified E. muris eauclairensis).
E. muris eauclairensis, formerly E. muris-like agent (EMLA)
- In 2009, a new Ehrlichia species was identified in patients in the upper Midwest.
- Formerly referred to as the “E. muris-like agent” (EMLA) this bacteria has now been formally named E. muris eauclairensis.
- Since its discovery, more than 115 cases of ehrlichiosis caused by E. muris eauclairensis have been reported. No deaths have been described.
- Page last reviewed: January 25, 2016
- Page last updated: January 25, 2016
- Content source: